KROS Keros Therapeutics, Inc.
Healthcare$11.19-0.27%ClosedMarket Cap: $358.1M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$102.60
Target (Median)
$105.00
Target Range
$96.00 - $107.00
Upside from current price: 816.9%
Rating Distribution
0 Strong Buy5 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-05 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-28 | B of A Securities | maintain | Neutral | Neutral |
| 2025-11-12 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-11-11 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-06 | Wedbush | maintain | Neutral | Neutral |
| 2025-08-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-10 | B of A Securities | downgrade | Neutral | Buy |
| 2025-05-30 | Wedbush | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-5.89 | $11.9M | 6 |
| Sun Dec 31 | $-4.07 | $56.5M | 7 |
| Mon Dec 31 | $-4.07 | $71.0M | 2 |
| Tue Dec 31 | $-2.37 | $111.0M | 5 |